Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research

Stay Informed: Medical and Research Updates
Connect With Us!


New Tool For Glaucoma Surgery Approved By FDA

More stable, precise delivery of scar reducing drug

February 10, 2012
Source: BrightFocus Foundation

The U.S. Food and Drug Administration has granted Mobius Therapeutics, LLC final approval for MitosolTM, a new drug delivery device for glaucoma surgery. Mitosol will help surgeons to deliver a precise dose of the device's active ingredient, mitomycin-c—a drug already used to reduce the scar tissue that may lead to increased eye pressure. Mitomycin-c is naturally unstable and hard to prepare in the operating room. However, the room-temperature storage Mitosol device provides a more convenient, stable version of the drug in pre-measured units to help ensure the same quality for each surgery. Mobius Therapeutics will begin marketing and manufacturing the device immediately. It should be noted that surgery is generally reserved for the most advanced cases of glaucoma.

Although mitomycin-c has been used in glaucoma surgeries, other methods of reducing scarring are currently under development, including BrightFocus-sponsored investigator Dr. Hiroshi Nakamura, who is using novel genetic methods to suppress the body's ability to generate scar tissue.


View all news updates for glaucoma

Disclaimer: The information provided in this section is a public service of the BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.

Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.

YouTube Twitter YouTube Shop for a Cause Connect With Us Pinterest Google+